Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera

被引：0
|
作者：
Joan How
Gabriela Hobbs
机构：
[1] Massachusetts General Hospital,Department of Medical Oncology
[2] Harvard Medical School,Division of Hematology, Department of Medicine
[3] Brigham and Women’s Hospital,Department of Medical Oncology, Dana
[4] Harvard Medical School,Farber Cancer Institute
[5] Harvard Medical School,undefined
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Essential thrombocythemia; Polycythemia vera; Low-risk; Myeloproliferative neoplasm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 482
页数：9
相关论文
共 50 条
  • [1] Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
    How, Joan
    Hobbs, Gabriela
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 473 - 482
  • [2] Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions
    Hannah Goulart
    John Mascarenhas
    Douglas Tremblay
    [J]. Annals of Hematology, 2022, 101 : 935 - 951
  • [3] Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions
    Goulart, Hannah
    Mascarenhas, John
    Tremblay, Douglas
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (05) : 935 - 951
  • [4] Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Patients With Low-Risk Essential Thrombocythemia and Polycythemia Vera
    Gangat, Naseema
    Wolanskyj, Alexandra P.
    Schwager, Susan M.
    Hanson, Curtis A.
    Tefferi, Ayalew
    [J]. CANCER, 2009, 115 (24) : 5740 - 5745
  • [5] Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Low-Risk Essential Thrombocythemia and Polycythemia Vera
    Gangat, Naseema
    Wolanskyj, Alexandra
    Schwager, Susan
    Hanson, Curtis A.
    Tefferi, Ayalew
    [J]. BLOOD, 2008, 112 (11) : 618 - 618
  • [6] Management of symptoms in polycythemia vera and essential thrombocythemia patients
    Radia, Deepti
    Geyer, Holly L.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 340 - 348
  • [7] Quality of life issues in patients with essential thrombocythemia and polycythemia vera
    Hoffman, R
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 3 - 9
  • [8] Updates in the management of polycythemia vera and essential thrombocythemia
    Bose, Prithvirai
    Verstovsek, Srdan
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [9] The risk of thrombosis in essential thrombocythemia and polycythemia vera
    Pearson, TC
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 16 - 21
  • [10] \ Erythromelalgia in patients with essential thrombocythemia and polycythemia vera
    Hou, Jennifer L.
    Onajin, Oluwakemi
    Gangat, Naseema
    Davis, Mark D. P.
    Wolanskyj, Alexandra P.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 715 - 717
12345